Antiplatelets and Anticoagulation Post-PCI: More on MASTER DAPT Antiplatelets and Anticoagulation Post-PCI: More on MASTER DAPT

New analysis from the MASTER DAPT trial of shortened DAPT in high bleeding risk patients focuses on oral anticoagulants, with experts in the field differing somewhat on interpretation of the results.Medscape Medical News

Source: Medscape Cardiology Headlines - September 1, 2021 Category: Cardiology Tags: Cardiology News Source Type: news